These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 18033003

  • 1. [A familial form of conduction defects associated with a PRKAG2 gene mutation].
    Pochmalicki G, Genest M, Richard P, Komajda M, Charron P.
    Arch Mal Coeur Vaiss; 2007 Sep; 100(9):760-5. PubMed ID: 18033003
    [Abstract] [Full Text] [Related]

  • 2. A familial form of conduction defect related to a mutation in the PRKAG2 gene.
    Charron P, Genest M, Richard P, Komajda M, Pochmalicki G.
    Europace; 2007 Aug; 9(8):597-600. PubMed ID: 17483151
    [Abstract] [Full Text] [Related]

  • 3. Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy.
    Gollob MH, Seger JJ, Gollob TN, Tapscott T, Gonzales O, Bachinski L, Roberts R.
    Circulation; 2001 Dec 18; 104(25):3030-3. PubMed ID: 11748095
    [Abstract] [Full Text] [Related]

  • 4. [Same genotype and different phenotypes in a family with PRKAG2 gene mutation].
    Hong K, Oliva A, Cheng XS, Brugada P, Brugada J, Sternick EB, Brugada R.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jun 18; 35(6):552-4. PubMed ID: 17711718
    [Abstract] [Full Text] [Related]

  • 5. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome.
    Gollob MH, Green MS, Tang AS, Gollob T, Karibe A, Ali Hassan AS, Ahmad F, Lozado R, Shah G, Fananapazir L, Bachinski LL, Roberts R.
    N Engl J Med; 2001 Jun 14; 344(24):1823-31. PubMed ID: 11407343
    [Abstract] [Full Text] [Related]

  • 6. Familial Atrial Enlargement, Conduction Disorder and Symmetric Cardiac Hypertrophy Are Early Signs of PRKAG2 R302Q.
    Hu J, Tang B, Wang J, Huang K, Wang Y, Lu S, Gowreesunkur HB, Wang Y, Wu D, Mayala HA, Wang ZH.
    Curr Med Sci; 2020 Jun 14; 40(3):486-492. PubMed ID: 32681253
    [Abstract] [Full Text] [Related]

  • 7. Molecular genetic analysis of PRKAG2 in sporadic Wolff-Parkinson-White syndrome.
    Vaughan CJ, Hom Y, Okin DA, McDermott DA, Lerman BB, Basson CT.
    J Cardiovasc Electrophysiol; 2003 Mar 14; 14(3):263-8. PubMed ID: 12716108
    [Abstract] [Full Text] [Related]

  • 8. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy.
    Arad M, Benson DW, Perez-Atayde AR, McKenna WJ, Sparks EA, Kanter RJ, McGarry K, Seidman JG, Seidman CE.
    J Clin Invest; 2002 Feb 14; 109(3):357-62. PubMed ID: 11827995
    [Abstract] [Full Text] [Related]

  • 9. Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy.
    Arad M, Moskowitz IP, Patel VV, Ahmad F, Perez-Atayde AR, Sawyer DB, Walter M, Li GH, Burgon PG, Maguire CT, Stapleton D, Schmitt JP, Guo XX, Pizard A, Kupershmidt S, Roden DM, Berul CI, Seidman CE, Seidman JG.
    Circulation; 2003 Jun 10; 107(22):2850-6. PubMed ID: 12782567
    [Abstract] [Full Text] [Related]

  • 10. Ventricular pre-excitation and cardiac hypertrophy mimicking hypertrophic cardiomyopathy in a Turkish family with a novel PRKAG2 mutation.
    Bayrak F, Komurcu-Bayrak E, Mutlu B, Kahveci G, Basaran Y, Erginel-Unaltuna N.
    Eur J Heart Fail; 2006 Nov 10; 8(7):712-5. PubMed ID: 16716659
    [Abstract] [Full Text] [Related]

  • 11. Glycogen storage diseases presenting as hypertrophic cardiomyopathy.
    Arad M, Maron BJ, Gorham JM, Johnson WH, Saul JP, Perez-Atayde AR, Spirito P, Wright GB, Kanter RJ, Seidman CE, Seidman JG.
    N Engl J Med; 2005 Jan 27; 352(4):362-72. PubMed ID: 15673802
    [Abstract] [Full Text] [Related]

  • 12. Transgenic mouse model of ventricular preexcitation and atrioventricular reentrant tachycardia induced by an AMP-activated protein kinase loss-of-function mutation responsible for Wolff-Parkinson-White syndrome.
    Sidhu JS, Rajawat YS, Rami TG, Gollob MH, Wang Z, Yuan R, Marian AJ, DeMayo FJ, Weilbacher D, Taffet GE, Davies JK, Carling D, Khoury DS, Roberts R.
    Circulation; 2005 Jan 04; 111(1):21-9. PubMed ID: 15611370
    [Abstract] [Full Text] [Related]

  • 13. Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome: natural history.
    Murphy RT, Mogensen J, McGarry K, Bahl A, Evans A, Osman E, Syrris P, Gorman G, Farrell M, Holton JL, Hanna MG, Hughes S, Elliott PM, Macrae CA, McKenna WJ.
    J Am Coll Cardiol; 2005 Mar 15; 45(6):922-30. PubMed ID: 15766830
    [Abstract] [Full Text] [Related]

  • 14. Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency.
    Burwinkel B, Scott JW, Bührer C, van Landeghem FK, Cox GF, Wilson CJ, Grahame Hardie D, Kilimann MW.
    Am J Hum Genet; 2005 Jun 15; 76(6):1034-49. PubMed ID: 15877279
    [Abstract] [Full Text] [Related]

  • 15. PRKAG2 cardiac syndrome: familial ventricular preexcitation, conduction system disease, and cardiac hypertrophy.
    Gollob MH, Green MS, Tang AS, Roberts R.
    Curr Opin Cardiol; 2002 May 15; 17(3):229-34. PubMed ID: 12015471
    [Abstract] [Full Text] [Related]

  • 16. Familial pseudo-Wolff-Parkinson-White syndrome.
    Sternick EB, Oliva A, Magalhães LP, Gerken LM, Hong K, Santana O, Brugada P, Brugada J, Brugada R.
    J Cardiovasc Electrophysiol; 2006 Jul 15; 17(7):724-32. PubMed ID: 16836667
    [Abstract] [Full Text] [Related]

  • 17. A new mutation in PRKAG2 gene causing hypertrophic cardiomyopathy with conduction system disease and muscular glycogenosis.
    Laforêt P, Richard P, Said MA, Romero NB, Lacene E, Leroy JP, Baussan C, Hogrel JY, Lavergne T, Wahbi K, Hainque B, Duboc D.
    Neuromuscul Disord; 2006 Mar 15; 16(3):178-82. PubMed ID: 16487706
    [Abstract] [Full Text] [Related]

  • 18. Electrophysiologic characterization and postnatal development of ventricular pre-excitation in a mouse model of cardiac hypertrophy and Wolff-Parkinson-White syndrome.
    Patel VV, Arad M, Moskowitz IP, Maguire CT, Branco D, Seidman JG, Seidman CE, Berul CI.
    J Am Coll Cardiol; 2003 Sep 03; 42(5):942-51. PubMed ID: 12957447
    [Abstract] [Full Text] [Related]

  • 19. Human γ2-AMPK Mutations.
    Yavari A, Sarma D, Sternick EB.
    Methods Mol Biol; 2018 Sep 03; 1732():581-619. PubMed ID: 29480501
    [Abstract] [Full Text] [Related]

  • 20. Fatal infantile cardiac glycogenosis with phosphorylase kinase deficiency and a mutation in the gamma2-subunit of AMP-activated protein kinase.
    Akman HO, Sampayo JN, Ross FA, Scott JW, Wilson G, Benson L, Bruno C, Shanske S, Hardie DG, Dimauro S.
    Pediatr Res; 2007 Oct 03; 62(4):499-504. PubMed ID: 17667862
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.